Positron emission tomography (PET). The maximum standardized uptake value of the preoperative lesion was 6.8 (arrows). (PPTX 120 kb
One patient in the CRT[−] group with polypoid esophageal cancer and unexpectedly high fluorodeoxyglu...
Follow-up ultrasound and abdominal CT radiographs at 6-month (A), 10-month (B, C, D) and 13-month fo...
Figure S1. Kaplan-Meier diagrams showing PFS (A) and OS (B) for subgroups according to the occurrenc...
Immunohistochemical staining. The tumor was positive for cytokeratin (CK)-7 and CK-20, and focally p...
Figure S1. Three-dimensional region of interest (ROI) replacement. SUVpeak of the tumor (arrows) was...
The “timeline” visualizes the course of treatment of the patient from the time of first detection of...
Figure S1. Time course multiparametric MR images with colorized MR maps overlaid on T2 weighted anat...
Figure S3. APC of incidence trend in anatomical region of pancreas: a. APC of incidence trend in dis...
Number of original publications concerning MIPD by year according to the study design (abstracts, le...
Additional file 1. Clinical characteristics of patients with pancreatic neuroendocrine neoplasms
Table S1. Clinicopathological characters associated with metastasis. (DOCX 22Â kb
Figure S1. Histology of the detected MSI gallbladder carcinoma. High magnification pictures of Hemat...
Pancreatic adenocarcinoma Incidence rates for each individual year (1973-2014). (DOCX 14 kb
Table S1. Pancreatic neuroendocrine neoplasia in MEN-1: Size, TNM, proliferation. A, B, C, E: total ...
Trends in Adenocarcinoma of head of pancreas and Adenocarcinoma of body and tail of pancreas Inciden...
One patient in the CRT[−] group with polypoid esophageal cancer and unexpectedly high fluorodeoxyglu...
Follow-up ultrasound and abdominal CT radiographs at 6-month (A), 10-month (B, C, D) and 13-month fo...
Figure S1. Kaplan-Meier diagrams showing PFS (A) and OS (B) for subgroups according to the occurrenc...
Immunohistochemical staining. The tumor was positive for cytokeratin (CK)-7 and CK-20, and focally p...
Figure S1. Three-dimensional region of interest (ROI) replacement. SUVpeak of the tumor (arrows) was...
The “timeline” visualizes the course of treatment of the patient from the time of first detection of...
Figure S1. Time course multiparametric MR images with colorized MR maps overlaid on T2 weighted anat...
Figure S3. APC of incidence trend in anatomical region of pancreas: a. APC of incidence trend in dis...
Number of original publications concerning MIPD by year according to the study design (abstracts, le...
Additional file 1. Clinical characteristics of patients with pancreatic neuroendocrine neoplasms
Table S1. Clinicopathological characters associated with metastasis. (DOCX 22Â kb
Figure S1. Histology of the detected MSI gallbladder carcinoma. High magnification pictures of Hemat...
Pancreatic adenocarcinoma Incidence rates for each individual year (1973-2014). (DOCX 14 kb
Table S1. Pancreatic neuroendocrine neoplasia in MEN-1: Size, TNM, proliferation. A, B, C, E: total ...
Trends in Adenocarcinoma of head of pancreas and Adenocarcinoma of body and tail of pancreas Inciden...
One patient in the CRT[−] group with polypoid esophageal cancer and unexpectedly high fluorodeoxyglu...
Follow-up ultrasound and abdominal CT radiographs at 6-month (A), 10-month (B, C, D) and 13-month fo...
Figure S1. Kaplan-Meier diagrams showing PFS (A) and OS (B) for subgroups according to the occurrenc...